{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:50:33Z","timestamp":1793994633932,"version":"4.8.0"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Metabolic disorders are highly prevalent in kidney transplant candidates and recipients and can adversely affect post-transplant graft outcomes. Management of diabetes, hyperparathyroidism, and obesity presents distinct opportunities to optimize patients both before and after transplant as well as the ability to track objective data over time to assess a patient\u2019s ability to partner effectively with the health care team and adhere to complex treatment regimens. Optimization of these particular disorders can most dramatically decrease the risk of surgical and cardiovascular complications post-transplant. Approximately 60% of nondiabetic patients experience hyperglycemia in the immediate post-transplant phase. Multiple risk factors have been identified related to development of new onset diabetes after transplant, and it is estimated that upward of 7%\u201330% of patients will develop new onset diabetes within the first year post-transplant. There are a number of medications studied in the kidney transplant population for diabetes management, and recent data and the risks and benefits of each regimen should be optimized. Secondary hyperparathyroidism occurs in most patients with CKD and can persist after kidney transplant in up to 66% of patients, despite an initial decrease in parathyroid hormone levels. Parathyroidectomy and medical management are the options for treatment of secondary hyperparathyroidism, but there is no randomized, controlled trial providing clear recommendations for optimal management, and patient-specific factors should be considered. Obesity is the most common metabolic disorder affecting the transplant population in both the pre- and post-transplant phases of care. Not only does obesity have associations and interactions with comorbid illnesses, such as diabetes, dyslipidemia, and cardiovascular disease, all of which increase morbidity and mortality post-transplant, but it also is intimately inter-related with access to transplantation for patients with kidney failure. We review these metabolic disorders and their management, including data in patients with kidney transplants.<\/jats:p>","DOI":"10.2215\/cjn.09310819","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T19:15:59Z","timestamp":1586805359000},"page":"732-742","source":"Crossref","is-referenced-by-count":52,"title":["Metabolic Disorders with Kidney Transplant"],"prefix":"10.2215","volume":"15","author":[{"given":"Elizabeth","family":"Cohen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Yale\u2013New Haven Hospital, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Korah","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Callender","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Endocrine Surgery, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Belfort de Aguiar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Haakinson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Transplant, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1681\/ASN.2017020216","article-title":"Understanding medication nonadherence after kidney transplant","volume":"28","author":"Nevins","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1600-6143.2007.02101.x","article-title":"Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes","volume":"8","author":"Cosio","year":"2008","journal-title":"Am J Transplant"},{"key":"B4-20230813","first-page":"356","article-title":"Outcomes of living donor kidney transplantation in diabetic patients: Age and sex matched comparison with non-diabetic patients","volume":"33","author":"Baek","year":"2018","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-8587(16)30317-5","article-title":"Long-term outcomes of kidney transplantation in people with type 2 diabetes: A population cohort study","volume":"5","author":"Lim","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/CRD.0000000000000216","article-title":"Obesity in kidney transplantation: Impact on transplant candidates, recipients, and donors","volume":"27","author":"Glicklich","year":"2019","journal-title":"Cardiol Rev"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ekir.2017.06.006","article-title":"Higher pretransplantation hemoglobin A1c Is associated with greater risk of posttransplant diabetes mellitus","volume":"2","author":"Shin","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrneph.2011.174","article-title":"Complications associated with new-onset diabetes after kidney transplantation","volume":"8","author":"Sharif","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1753-0407.12618","article-title":"Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study","volume":"10","author":"Jung","year":"2018","journal-title":"J Diabetes"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/dme.13383","article-title":"Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: An observational cohort study","volume":"34","author":"Johal","year":"2017","journal-title":"Diabet Med"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/dc11-0752","article-title":"Pretransplant risk score for new-onset diabetes after kidney transplantation","volume":"34","author":"Chakkera","year":"2011","journal-title":"Diabetes Care"},{"issue":"Suppl 3","key":"B12-20230813","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1681\/ASN.2006080929","article-title":"New-onset diabetes after kidney transplantation: Risk factors","volume":"17","author":"Rodrigo","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ekir.2019.04.028","article-title":"Adherence behavior in subjects on hemodialysis is not a clear predictor of posttransplantation adherence","volume":"4","author":"Hucker","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"Suppl 3","key":"B14-20230813","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ndt\/13.suppl_3.94","article-title":"Parathyroid function in long-term renal transplant patients: Importance of pre-transplant PTH concentrations","volume":"13","author":"Torres","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/ajt.12913","article-title":"Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia","volume":"14","author":"Coyne","year":"2014","journal-title":"Am J Transplant"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.surg.2016.10.003","article-title":"Parathyroidectomy prior to kidney transplant decreases graft failure","volume":"161","author":"Callender","year":"2017","journal-title":"Surgery"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1600-6143.2012.04186.x","article-title":"The AJT report: News and issues that affect organ and tissue transplantation","volume":"12","author":"Pondrom","year":"2012","journal-title":"Am J Transplant"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2007050610","article-title":"Obesity impacts access to kidney transplantation","volume":"19","author":"Segev","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s11695-017-2722-6","article-title":"Bariatric surgery as a bridge to renal transplantation in patients with end-stage renal disease","volume":"27","author":"Al-Bahri","year":"2017","journal-title":"Obes Surg"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/TP.0000000000000037","article-title":"Incidence of conversion to active waitlist status among temporarily inactive obese renal transplant candidates","volume":"98","author":"Huang","year":"2014","journal-title":"Transplantation"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trre.2016.12.002","article-title":"Management of the obese kidney transplant candidate","volume":"31","author":"Lesage","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2337\/diaclin.25.4.135","article-title":"Weight-loss pharmacotherapy: A brief review","volume":"25","author":"Huizinga","year":"2007","journal-title":"Clin Diabetes"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2009.09.011","article-title":"Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-Year follow-up","volume":"55","author":"MacLaughlin","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s11695-017-2854-8","article-title":"The role of bariatric surgery in abdominal organ transplantation\u2014the next big challenge?","volume":"27","author":"Dziodzio","year":"2017","journal-title":"Obes Surg"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ajt.14463","article-title":"Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients","volume":"18","author":"Kim","year":"2018","journal-title":"Am J Transplant"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"e13232","DOI":"10.1111\/ctr.13232","article-title":"Roux-en-Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center","volume":"32","author":"Thomas","year":"2018","journal-title":"Clin Transplant"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: Kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","article-title":"Importance of perioperative glycemic control in general surgery: A report from the Surgical Care and Outcomes Assessment Program","volume":"257","author":"Kwon","year":"2013","journal-title":"Ann Surg"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc10-0304","article-title":"Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery","volume":"33","author":"Frisch","year":"2010","journal-title":"Diabetes Care"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4239\/wjd.v9.i7.132","article-title":"New-onset diabetes after kidney transplantation: Incidence and associated factors","volume":"9","author":"Gomes","year":"2018","journal-title":"World J Diabetes"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/00007890-200110150-00024","article-title":"Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: A pilot study","volume":"72","author":"Thomas","year":"2001","journal-title":"Transplantation"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: Causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr Rev"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.diabet.2012.10.007","article-title":"Continuous glucose monitoring after kidney transplantation in non-diabetic patients: Early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure","volume":"39","author":"Wojtusciszyn","year":"2013","journal-title":"Diabetes Metab"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/petr.12106","article-title":"Continuous glucose monitoring system (CGMS) in kidney-transplanted children","volume":"17","author":"Pasti","year":"2013","journal-title":"Pediatr Transplant"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1681\/ASN.2011080835","article-title":"Early basal insulin therapy decreases new-onset diabetes after renal transplantation","volume":"23","author":"Hecking","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/193229681300700421","article-title":"Perioperative management of patients with diabetes undergoing ambulatory elective surgery","volume":"7","author":"Coan","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/ajt.13247","article-title":"New-onset diabetes after transplantation: Results from a double-blind early corticosteroid withdrawal trial","volume":"15","author":"Pirsch","year":"2015","journal-title":"Am J Transplant"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP15665.CO","article-title":"A role for transplant endocrinologists\u2014it\u2019s about time","volume":"21","author":"Rickels","year":"2015","journal-title":"Endocr Pract"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2337\/ds17-0029","article-title":"Positive impact of a pilot pharmacist-run diabetes pharmacotherapy clinic in solid-organ transplant recipients","volume":"31","author":"Newland","year":"2018","journal-title":"Diabetes Spectr"},{"key":"B42-20230813","first-page":"121","article-title":"Consequences of recipient obesity on postoperative outcomes in a renal transplant: A systematic review and meta-analysis","volume":"14","author":"Sood","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1542\/peds.2004-0289","article-title":"Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"115","author":"Hanevold","year":"2005","journal-title":"Pediatrics"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181b4ee9a","article-title":"Obesity, surgical site infection, and outcome following renal transplantation","volume":"250","author":"Lynch","year":"2009","journal-title":"Ann Surg"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/ajt.12078","article-title":"Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation","volume":"13","author":"Oberholzer","year":"2013","journal-title":"Am J Transplant"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s00268-013-2244-x","article-title":"State of the art of robotic surgery in organ transplantation","volume":"37","author":"Tzvetanov","year":"2013","journal-title":"World J Surg"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/TP.0000000000001249","article-title":"Single center experience with robotic kidney transplantation for recipients with BMI of 40 kg\/m2 or greater: A comparison with the UNOS registry","volume":"101","author":"Garcia-Roca","year":"2017","journal-title":"Transplantation"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.transproceed.2014.05.027","article-title":"Post-transplantation weight gain: Prevalence and the impact of steroid-free therapy","volume":"46","author":"de Oliveira","year":"2014","journal-title":"Transplant Proc"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ajt.12331","article-title":"The survival benefit of kidney transplantation in obese patients","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diaspect.21.1.30","article-title":"Management of hypertension in diabetic patients with chronic kidney disease","volume":"21","author":"Steigerwalt","year":"2008","journal-title":"Diabetes Spectr"},{"key":"B51-20230813","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: A narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B53-20230813","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3892\/etm.2016.3667","article-title":"Obesity and hypertension","volume":"12","author":"Jiang","year":"2016","journal-title":"Exp Ther Med"},{"key":"B54-20230813","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival","volume":"3","author":"Cole","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B55-20230813","first-page":"553","article-title":"Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients","volume":"12","author":"Sagedal","year":"1998","journal-title":"Clin Transplant"},{"key":"B56-20230813","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/01.TP.0000116393.98934.6F","article-title":"Rosiglitazone treatment of diabetes mellitus after solid organ transplantation","volume":"77","author":"Baldwin","year":"2004","journal-title":"Transplantation"},{"key":"B57-20230813","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1432-2277.2004.00076.x","article-title":"Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation","volume":"18","author":"Pietruck","year":"2005","journal-title":"Transpl Int"},{"key":"B58-20230813","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01250.x","article-title":"Repaglinide in the management of new-onset diabetes mellitus after renal transplantation","volume":"6","author":"T\u00fcrk","year":"2006","journal-title":"Am J Transplant"},{"key":"B59-20230813","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5414\/CNP70026","article-title":"Gliquidone therapy of new-onset diabetes mellitus after kidney transplantation","volume":"70","author":"Tuerk","year":"2008","journal-title":"Clin Nephrol"},{"key":"B60-20230813","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4158\/EP.14.8.979","article-title":"Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients","volume":"14","author":"Kurian","year":"2008","journal-title":"Endocr Pract"},{"key":"B61-20230813","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1159\/000370034","article-title":"Metformin use in kidney transplant recipients in the United States: An observational study","volume":"40","author":"Stephen","year":"2014","journal-title":"Am J Nephrol"},{"key":"B62-20230813","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation","volume":"92","author":"Lane","year":"2011","journal-title":"Transplantation"},{"key":"B63-20230813","doi-asserted-by":"crossref","first-page":"617638","DOI":"10.1155\/2014\/617638","article-title":"Efficacy and safety of sitagliptin for the treatment of new-onset diabetes after renal transplantation","volume":"2014","author":"Boerner","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B64-20230813","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/TP.0b013e318276a20e","article-title":"Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: A randomized, placebo-controlled clinical trial","volume":"95","author":"Werzowa","year":"2013","journal-title":"Transplantation"},{"key":"B65-20230813","first-page":"297","article-title":"Effects of vildagliptin (Galvus\u00ae) therapy in patients with type 2 diabetes mellitus after heart transplantation","volume":"7","author":"Gueler","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"B66-20230813","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.2337\/dc13-1066","article-title":"Coadministration of liraglutide with tacrolimus in kidney transplant recipients: A case series","volume":"36","author":"Pinelli","year":"2013","journal-title":"Diabetes Care"},{"key":"B67-20230813","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.transproceed.2018.03.087","article-title":"Managament of diabetes mellitus with glucagonlike peptide-1 agonist liraglutide in renal transplant recipients: A retrospective study","volume":"50","author":"Liou","year":"2018","journal-title":"Transplant Proc"},{"key":"B68-20230813","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Halden","year":"2019","journal-title":"Diabetes Care"},{"key":"B69-20230813","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.15223","article-title":"Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety","volume":"19","author":"Schwaiger","year":"2019","journal-title":"Am J Transplant"},{"key":"B70-20230813","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ndt\/gft536","article-title":"Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation","volume":"29","author":"Str\u00f8m Halden","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B71-20230813","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.1990.03450010067032","article-title":"Kidney transplantation under FK 506","volume":"264","author":"Starzl","year":"1990","journal-title":"JAMA"},{"key":"B72-20230813","first-page":"920","article-title":"Kidney transplantation under FK 506 immunosuppression","volume":"23","author":"Shapiro","year":"1991","journal-title":"Transplant Proc"},{"key":"B73-20230813","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1681\/ASN.V123583","article-title":"Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study","volume":"12","author":"Duijnhoven","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B74-20230813","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1681\/ASN.V131221","article-title":"Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction","volume":"13","author":"Boots","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B75-20230813","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/TP.0b013e31816b16bd","article-title":"Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: A prospective and multicenter study","volume":"85","author":"Porrini","year":"2008","journal-title":"Transplantation"},{"key":"B76-20230813","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"B77-20230813","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"B78-20230813","first-page":"146","article-title":"Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: A single-centre experience in renal transplanted patients and review of the literature","volume":"21","author":"Ghisdal","year":"2008","journal-title":"Transpl Int"},{"key":"B79-20230813","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"B80-20230813","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B81-20230813","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":"The ORION study: Comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume":"11","author":"Flechner","year":"2011","journal-title":"Am J Transplant"},{"key":"B82-20230813","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.transproceed.2011.05.001","article-title":"Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: A long-term analysis of various treatment regimens","volume":"43","author":"Gyurus","year":"2011","journal-title":"Transplant Proc"},{"key":"B83-20230813","doi-asserted-by":"crossref","first-page":"496974","DOI":"10.1155\/2013\/496974","article-title":"Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation","volume":"2013","author":"Veroux","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B84-20230813","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.2215\/CJN.00270111","article-title":"Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B85-20230813","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1097\/TXD.0000000000000767","article-title":"Improved glucose tolerance in a kidney transplant recipient with type 2 diabetes mellitus after switching from tacrolimus to belatacept: A case report and review of potential mechanisms","volume":"4","author":"de Graav","year":"2018","journal-title":"Transplant Direct"},{"key":"B86-20230813","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1111\/j.1399-0012.2011.01515.x","article-title":"Intact parathyroid hormone levels in renal transplant patients with normal transplant function","volume":"25","author":"Bleskestad","year":"2011","journal-title":"Clin Transplant"},{"key":"B87-20230813","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/TP.0000000000000583","article-title":"Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism","volume":"99","author":"Pihlstr\u00f8m","year":"2015","journal-title":"Transplantation"},{"key":"B88-20230813","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B89-20230813","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","article-title":"Management of post-transplant hyperparathyroidism and bone disease","volume":"79","author":"Delos Santos","year":"2019","journal-title":"Drugs"},{"key":"B90-20230813","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000368514","article-title":"Long-term outcomes of parathyroidectomy in kidney transplant recipients with persistent hyperparathyroidism","volume":"40","author":"Tseng","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"B91-20230813","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MNH.0b013e32803578e4","article-title":"Obesity and kidney disease: A big dilemma","volume":"16","author":"Kramer","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B92-20230813","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/ckj\/sfx022","article-title":"Obesity and listing for renal transplantation: Weighing the evidence for a growing problem","volume":"10","author":"Hossain","year":"2017","journal-title":"Clin Kidney J"},{"key":"B93-20230813","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e31819e3f14","article-title":"Bariatric surgery among kidney transplant candidates and recipients: Analysis of the United States renal data system and literature review","volume":"87","author":"Modanlou","year":"2009","journal-title":"Transplantation"},{"key":"B94-20230813","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/ajt.13166","article-title":"Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy","volume":"15","author":"Freeman","year":"2015","journal-title":"Am J Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.09310819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:18Z","timestamp":1786369218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.09310819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.09310819","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]}}}